Variant report
Variant | esv3366040 |
---|---|
Chromosome Location | chr17:50854303-50856901 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573486077 | chr17:50854382-50854383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4635383 | chr17:50854419-50854420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs185913452 | chr17:50854430-50854431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190934441 | chr17:50854470-50854471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562078754 | chr17:50854528-50854529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7226032 | chr17:50854564-50854565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs116224984 | chr17:50854572-50854573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs367823068 | chr17:50854584-50854585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7225600 | chr17:50854658-50854659 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs533264674 | chr17:50854710-50854711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546778974 | chr17:50854748-50854749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34531676 | chr17:50854750-50854751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141524431 | chr17:50854765-50854766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146354750 | chr17:50854815-50854816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181333042 | chr17:50854862-50854863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145494184 | chr17:50854897-50854898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs202191230 | chr17:50854898-50854899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78276990 | chr17:50854899-50854900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72525907 | chr17:50854910-50854911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75101298 | chr17:50854911-50854912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548775804 | chr17:50854931-50854932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568589751 | chr17:50854951-50854952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551177700 | chr17:50854958-50854959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569403815 | chr17:50854966-50854967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376132090 | chr17:50854982-50854983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185804581 | chr17:50854991-50854992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533457530 | chr17:50855089-50855090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570854548 | chr17:50855111-50855112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539696700 | chr17:50855129-50855130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535923987 | chr17:50855177-50855178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71372131 | chr17:50855180-50855181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374725965 | chr17:50855181-50855182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4505387 | chr17:50855182-50855183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs58669546 | chr17:50855184-50855185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60704936 | chr17:50855187-50855188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs3041637 | chr17:50855191-50855192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4636952 | chr17:50855192-50855193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368458743 | chr17:50855237-50855238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535963488 | chr17:50855302-50855303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555934739 | chr17:50855320-50855321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575801543 | chr17:50855329-50855330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190571776 | chr17:50855357-50855358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs36118312 | chr17:50855362-50855363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs58786854 | chr17:50855393-50855394 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs72830616 | chr17:50855412-50855413 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs540122883 | chr17:50855414-50855415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560318383 | chr17:50855415-50855416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567767118 | chr17:50855437-50855438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549145558 | chr17:50855487-50855488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369715450 | chr17:50855495-50855496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Chordoma | 18071362 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:50853400-50854800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr17:50854600-50856800 | Enhancers | HUVEC | blood vessel |